Sosei Group
Japanese biopharmaceutical company that develops and commercializes innovative drugs..
Launch date
Employees
Market cap
CAD1.2b
Enterprise valuation
CAD1.4b (Public information from Sep 2024)
Share price
$16.55 4565.T
Tokyo Japan (HQ)
Corporate Venture Fund: Sosei CVC
Financials
Estimates*
JPY | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Revenues | 9.7b | 8.8b | 17.7b | 15.6b | 12.8b | 4.9b | 5.2b |
% growth | 239 % | (9 %) | 100 % | (12 %) | (18 %) | (62 %) | 7 % |
EBITDA | 2.5b | 3.6b | 5.3b | 5.0b | (5.7b) | - | - |
% EBITDA margin | 26 % | 40 % | 30 % | 32 % | (45 %) | - | - |
Profit | 1.4b | 1.5b | 1.0b | 382m | (7.2b) | - | - |
% profit margin | 15 % | 17 % | 6 % | 2 % | (56 %) | - | - |
R&D budget | 4.3b | 3.8b | 5.9b | 7.5b | 10.1b | - | - |
R&D % of revenue | 44 % | 43 % | 33 % | 48 % | 79 % | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$13.0m | Series B | ||
N/A | N/A | IPO | |
N/A | £29.0m | Post IPO Equity | |
N/A | Post IPO Equity | ||
N/A | $200m | Post IPO Convertible | |
Total Funding | CAD17.7m |
Related Content
Recent News about Sosei Group
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Sosei Group
EditACQUISITION by Sosei Group Feb 2015
ACQUISITION by Sosei Group Jul 2005
ACQUISITION Apr 2021